Caplacizumab, CAS 915810-67-2

Product Description: Caplacizumab (ALX-0681) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP)[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Maëlle le Besnerais, et al. Caplacizumab: a change in the paradigm of thrombotic thrombocytopenic purpura treatment. Expert Opin Biol Ther. 2019 Nov;19(11):1127-1134.

CAS Number: 915810-67-2

Molecular Weight: N/A

Compound Purity: 99.98

Research Area: Cancer; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99227-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99227-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK